持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/07/11 | 7,810 | 7,910 | 7,800 | 7,890 | +50 | +0.6% | 24,000 |
| 2017/07/10 | 7,940 | 7,940 | 7,840 | 7,840 | -40 | -0.5% | 29,600 |
| 2017/07/07 | 7,920 | 7,940 | 7,860 | 7,880 | -80 | -1% | 34,400 |
| 2017/07/06 | 8,010 | 8,030 | 7,940 | 7,960 | -10 | -0.1% | 25,300 |
| 2017/07/05 | 8,010 | 8,040 | 7,920 | 7,970 | -40 | -0.5% | 26,700 |
| 2017/07/04 | 8,080 | 8,090 | 7,980 | 8,010 | -80 | -1% | 33,400 |
| 2017/07/03 | 8,020 | 8,130 | 8,020 | 8,090 | -10 | -0.1% | 36,600 |
| 2017/06/30 | 8,050 | 8,120 | 8,040 | 8,100 | -100 | -1.2% | 38,000 |
| 2017/06/29 | 8,050 | 8,210 | 8,040 | 8,200 | +150 | +1.9% | 56,900 |
| 2017/06/28 | 8,100 | 8,120 | 8,050 | 8,050 | -50 | -0.6% | 31,500 |
| 2017/06/27 | 8,140 | 8,170 | 8,090 | 8,100 | -40 | -0.5% | 29,300 |
| 2017/06/26 | 8,140 | 8,190 | 8,110 | 8,140 | +40 | +0.5% | 39,300 |
| 2017/06/23 | 8,080 | 8,130 | 8,060 | 8,100 | +10 | +0.1% | 29,500 |
| 2017/06/22 | 8,060 | 8,110 | 8,060 | 8,090 | +30 | +0.4% | 23,500 |
| 2017/06/21 | 7,990 | 8,090 | 7,990 | 8,060 | +40 | +0.5% | 31,500 |
| 2017/06/20 | 7,950 | 8,060 | 7,900 | 8,020 | +60 | +0.8% | 40,200 |
| 2017/06/19 | 7,840 | 7,990 | 7,830 | 7,960 | +60 | +0.8% | 40,200 |
| 2017/06/16 | 7,970 | 8,000 | 7,880 | 7,900 | -30 | -0.4% | 55,600 |
| 2017/06/15 | 7,860 | 7,990 | 7,830 | 7,930 | +120 | +1.5% | 50,500 |
| 2017/06/14 | 7,840 | 7,900 | 7,810 | 7,810 | +20 | +0.3% | 41,400 |
| 2017/06/13 | 7,860 | 7,870 | 7,790 | 7,790 | -60 | -0.8% | 30,600 |
| 2017/06/12 | 7,720 | 7,910 | 7,720 | 7,850 | +130 | +1.7% | 64,500 |
| 2017/06/09 | 7,770 | 7,830 | 7,700 | 7,720 | -50 | -0.6% | 55,600 |
| 2017/06/08 | 7,780 | 7,830 | 7,740 | 7,770 | -20 | -0.3% | 40,900 |
| 2017/06/07 | 7,910 | 7,910 | 7,780 | 7,790 | -90 | -1.1% | 50,600 |
| 2017/06/06 | 8,030 | 8,030 | 7,880 | 7,880 | -180 | -2.2% | 44,500 |
| 2017/06/05 | 8,000 | 8,080 | 7,980 | 8,060 | +60 | +0.8% | 50,300 |
| 2017/06/02 | 8,020 | 8,030 | 7,960 | 8,000 | +20 | +0.3% | 60,300 |
| 2017/06/01 | 7,880 | 7,990 | 7,880 | 7,980 | +150 | +1.9% | 45,700 |
| 2017/05/31 | 7,910 | 7,950 | 7,830 | 7,830 | -90 | -1.1% | 46,400 |
| 2017/05/30 | 7,960 | 7,980 | 7,900 | 7,920 | -50 | -0.6% | 22,800 |
| 2017/05/29 | 8,060 | 8,100 | 7,960 | 7,970 | -70 | -0.9% | 48,900 |
| 2017/05/26 | 8,160 | 8,170 | 8,010 | 8,040 | -160 | -2% | 60,800 |
| 2017/05/25 | 8,280 | 8,320 | 8,180 | 8,200 | -150 | -1.8% | 53,300 |
| 2017/05/24 | 8,480 | 8,540 | 8,310 | 8,350 | -130 | -1.5% | 48,100 |
| 2017/05/23 | 8,560 | 8,610 | 8,450 | 8,480 | -110 | -1.3% | 49,800 |
| 2017/05/22 | 8,640 | 8,640 | 8,550 | 8,590 | -120 | -1.4% | 45,000 |
| 2017/05/19 | 8,800 | 8,800 | 8,660 | 8,710 | -70 | -0.8% | 32,900 |
| 2017/05/18 | 8,780 | 8,840 | 8,740 | 8,780 | -70 | -0.8% | 46,100 |
| 2017/05/17 | 8,890 | 8,960 | 8,840 | 8,850 | -80 | -0.9% | 49,300 |
| 2017/05/16 | 8,910 | 8,980 | 8,820 | 8,930 | -40 | -0.4% | 76,500 |
| 2017/05/15 | 8,720 | 9,040 | 8,720 | 8,970 | +140 | +1.6% | 53,700 |
| 2017/05/12 | 8,750 | 8,850 | 8,740 | 8,830 | ±0 | ±0% | 26,900 |
| 2017/05/11 | 8,760 | 8,880 | 8,760 | 8,830 | -50 | -0.6% | 38,100 |
| 2017/05/10 | 8,780 | 8,890 | 8,760 | 8,880 | +70 | +0.8% | 30,800 |
| 2017/05/09 | 8,730 | 8,820 | 8,680 | 8,810 | +20 | +0.2% | 30,700 |
| 2017/05/08 | 8,590 | 8,840 | 8,520 | 8,790 | +360 | +4.3% | 72,300 |
| 2017/05/02 | 8,380 | 8,470 | 8,370 | 8,430 | -40 | -0.5% | 41,400 |
| 2017/05/01 | 8,410 | 8,490 | 8,390 | 8,470 | +70 | +0.8% | 22,600 |
| 2017/04/28 | 8,380 | 8,430 | 8,320 | 8,400 | +80 | +1% | 33,900 |
1801～
1850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
